A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017

Clinical trial NCT06388551 · UNKNOWN

Trial details

NCT number: NCT06388551
Sponsor: Luye Pharma Group Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis Hallucinations and Delusions Associated With Parkinson Disease Psychosis Negative Symptoms of Schizophrenia

Start date: 2024-05-10
Primary completion: 2025-03-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.